Clinical Trial Update: Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the concomitant use of ixekizumab and tirzepatide in adults with psoriatic arthritis who are obese or overweight; the study status is a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Psoriatic Arthritis

Drugs mentioned

• Ixekizumab (ixekizumab)
• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Psoriatic Arthritis, Obesity | Phase 3 | Status: ACTIVE_NOT_RECRUITING